W. Daniel Stamer, PhD

W. Daniel Stamer, Ph.D. currently serves as the Joseph A.C. Wadsworth Professor of Ophthalmology and Professor of Biomedical Engineering at Duke University. Professor Stamer was educated at the University of Arizona, earning his bachelors of science in Molecular and Cellular Biology in 1990 and doctorate in Pharmacology and Toxicology in 1996. He completed two research fellowships: the first with Dr. Andrea Yool in electrophysiology and the second with Dr. David Epstein in glaucoma/cell biology.

Professor Stamer started his research program in 1998 at the University of Arizona, where he remained for 13 years, rising through the ranks to full Professor and Director of Ophthalmic Research. He joined the faculty at the Duke Eye Center in 2011. Notable recent accomplishments include the Rudin Prize for Glaucoma in 2012, the RPB Senior Scientific Investigator Award in 2013 and election as ARVO Trustee in 2015 and president in 2018. He currently holds prominent editorial positions in three premier ophthalmology journals: as Editor-in-Chief for the Journal of Ocular Pharmacology and Therapeutics, member of editorial board Investigative Ophthalmology and Visual Science and executive editor of Experimental Eye Research. In addition to 39 collaborative projects with 11 pharmaceutical companies, he NIH has continuously funded Professor Stamer’s research for the past 18 years. His work is documented in 140 original articles, 27 review articles/book chapters and 19 editorials. The primary research focus of the Stamer Laboratory is to understand the molecular and cellular mechanisms that regulate conventional outflow in health, and the dysregulation that occurs in disease leading to ocular hypertension.